EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol

Clinical trial NCT01119261 · COMPLETED

Trial details

NCT number: NCT01119261
Sponsor: Utrecht Institute for Pharmaceutical Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Venous Thromboembolism Atrial Fibrillation

Start date: 2010-11-01
Primary completion: 2013-06-01
Enrollment: 970

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.